This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Omeprazole | Pantoprazole | |
|---|---|---|
| Active Substances | OMEPRAZOLE | pantoprazole |
| ATC Code | A02BC01 | A02BC02 |
| Form | TABLET, DELAYED RELEASE | — |
| Dosage | 20 mg/1 | — |
| Route | ORAL | — |
| Manufacturer | Meijer, Inc. | Takeda GmbH |
| Indications | — | This medication is a proton-pump inhibitor, prescribed for gastroesophageal reflux disease (GERD), ulcers, Zollinger-Ellison Syndrome, and erosive esophagitis. It decreases the amount of acid made in the stomach. |
| Side Effects | — | Central Nervous System - Headache, anxiety, weakness, dizziness, muscle tightness, migraine, sleeplessness, damage to the eye nerve, confusion, increased potassium level in blood, speech disorder, tinnitus, uneasiness, fatigue, vertigo. Skin - Rash, severe allergic reactions (eg, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis). Eye and ENT - Inflammation of pharynx, stuffy nose, blurred vision. Gastrointestinal - Nausea, vomiting, diarrhea, pain, constipation, rarely inflammation of pancreas. Genitourinary - Urinary frequency, urinary tract infection, kidney disease, creatinine increased. Blood - Pancytopenia- decrease of all types of blood cells, including red and white blood cells as well as platelets. Liver - Increased liver enzymes, liver cells damage leading to jaundice and liver failure. Local - Injection-site reactions (including abscess, thrombophlebitis). Metabolic - Increase in fat, sugar, cholesterol, weight changes, uric acid in the blood. Musculoskeletal - Joint pain, back pain, neck pain. Respiratory - Asthma, cough, difficulty in breathing, upper respiratory tract infection. Miscellaneous - Chest pain, flu syndrome, infection, severe and life-threatening reaction. |
Omeprazole (INN: OMEPRAZOLE, ATC A02BC01) and Pantoprazole (INN: pantoprazole, ATC A02BC02) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
| Warnings | — | •Long-term therapy may lead to bacterial overgrowth in the GI tract, atrophic gastritis. Monitor liver function regularly (if enzymes increase, discontinue) because it may lead to liver damage. Caution needed during pregnancy; not recommended in children <18 year. ♦ Patient may develop with increased risk of Clostridium difficile associated diarrhea (CDAD). |
|---|